|
Volumn 4, Issue 3, 2015, Pages e001349-
|
Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial
a a a a a a a b b a a a a a a |
Author keywords
anticoagulants; arrhythmia; embolism; prevention; risk factors
|
Indexed keywords
ANTICOAGULANT AGENT;
WARFARIN;
AGED;
ASIA;
ATRIAL FIBRILLATION;
BLOOD;
BLOOD CLOTTING;
CLINICAL TRIAL;
COMPARATIVE STUDY;
COMPLICATION;
CONTROLLED STUDY;
DOSE CALCULATION;
DRUG EFFECTS;
DRUG MONITORING;
EMBOLISM;
EUROPE;
FEMALE;
HUMAN;
INTERNATIONAL NORMALIZED RATIO;
MALE;
MULTICENTER STUDY;
NORTH AMERICA;
PREDICTIVE VALUE;
PROCEDURES;
RANDOMIZED CONTROLLED TRIAL;
SOUTH AFRICA;
SOUTH AND CENTRAL AMERICA;
STROKE;
TIME FACTOR;
TREATMENT OUTCOME;
AGED;
ANTICOAGULANTS;
ASIA;
ATRIAL FIBRILLATION;
BLOOD COAGULATION;
DRUG DOSAGE CALCULATIONS;
DRUG MONITORING;
EMBOLISM;
EUROPE;
FEMALE;
HUMANS;
INTERNATIONAL NORMALIZED RATIO;
LATIN AMERICA;
MALE;
NORTH AMERICA;
PREDICTIVE VALUE OF TESTS;
SOUTH AFRICA;
STROKE;
TIME FACTORS;
TREATMENT OUTCOME;
WARFARIN;
|
EID: 85016515423
PISSN: None
EISSN: 20479980
Source Type: Journal
DOI: 10.1161/JAHA.114.001349 Document Type: Article |
Times cited : (11)
|
References (0)
|